Payment overview · 2025
General Payments
$104.94
6 reported records · 2 companies
Healthcare provider profile · identity verified
Ching-Yin Lam, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · NEW YORK, NY · NPI 1487640900
Verified facts
What the public records show
CMS Open Payments records show Ching-Yin Lam, M.D. received $104.94 in general payments during 2025 across 6 reported records.
GlaxoSmithKline, LLC. accounted for 52.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 54 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 67 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $54.70 | 52.1% | 3 | 2025 |
| Seqirus USA Inc | Unresolved — no canonical attribution shown | $50.24 | 47.9% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $104.94 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $54.70 | 3 | 2025 |
Source payment records
|
|||||
| Fluad Normalized: fluad |
Biological | Seqirus USA Inc | $50.24 | 3 | 2025 |
Source payment records
|
|||||
| Flucelvax Normalized: flucelvax |
Biological | Seqirus USA Inc | $15.33 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 67 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
54 | 29 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
67 | 15 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 1417 | 254 |
| Amlodipine Besylate | Amlodipine Besylate | 1186 | 223 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1068 | 193 |
| Losartan Potassium | Losartan Potassium | 1063 | 183 |
| Metoprolol Succinate | Metoprolol Succinate | 934 | 160 |
| Omeprazole | Omeprazole | 867 | 182 |
| Raloxifene Hcl | Raloxifene Hcl | 840 | 128 |
| Gabapentin | Gabapentin | 666 | 133 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 571 | 105 |
| Vascepa | Icosapent Ethyl | 498 | 66 |
| Tamsulosin Hcl | Tamsulosin Hcl | 453 | 91 |
| Finasteride | Finasteride | 435 | 85 |
| Metformin Hcl | Metformin Hcl | 432 | 77 |
| Montelukast Sodium | Montelukast Sodium | 429 | 90 |
| Farxiga | Dapagliflozin Propanediol | 409 | 63 |
| Simvastatin | Simvastatin | 407 | 71 |
| Ammonium Lactate | Ammonium Lactate | 405 | 98 |
| Meclizine Hcl | Meclizine Hcl | 398 | 148 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 381 | 73 |
| Memantine Hcl Er | Memantine Hcl | 368 | 47 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 361 | 106 |
| Clobetasol Propionate | Clobetasol Propionate | 347 | 90 |
| Levothyroxine Sodium | Levothyroxine Sodium | 344 | 58 |
| Famotidine | Famotidine | 343 | 64 |
| Diclofenac Epolamine | Diclofenac Epolamine | 317 | 57 |
| Diclofenac Sodium | Diclofenac Sodium | 317 | 95 |
| Quetiapine Fumarate | Quetiapine Fumarate | 300 | 56 |
| Fluticasone Propionate | Fluticasone Propionate | 287 | 73 |
| Azithromycin | Azithromycin | 283 | 219 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 282 | 56 |
| Jardiance | Empagliflozin | 272 | 40 |
| Januvia | Sitagliptin Phosphate | 267 | 47 |
| Glipizide Er | Glipizide | 261 | 41 |
| Clopidogrel | Clopidogrel Bisulfate | 246 | 41 |
| Lisinopril | Lisinopril | 241 | 44 |
| Colchicine | Colchicine | 237 | 49 |
| Eliquis | Apixaban | 235 | 36 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 231 | 77 |
| Allopurinol | Allopurinol | 229 | 46 |
| Azelastine Hcl | Azelastine Hcl | 228 | 48 |
| Fluconazole | Fluconazole | 228 | 39 |
| Celecoxib | Celecoxib | 205 | 48 |
| Bepotastine Besilate | Bepotastine Besilate | 204 | 39 |
| Linzess | Linaclotide | 204 | 26 |
| Baclofen | Baclofen | 203 | 63 |
| Mometasone Furoate | Mometasone Furoate | 185 | 61 |
| Furosemide | Furosemide | 183 | 38 |
| Glimepiride | Glimepiride | 183 | 35 |
| Potassium Chloride | Potassium Chloride | 166 | 38 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 164 | 27 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 162 | 36 |
| Carvedilol | Carvedilol | 161 | 32 |
| Pantoprazole Sodium | Pantoprazole Sodium | 158 | 34 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 153 | 36 |
| Tradjenta | Linagliptin | 152 | 22 |
| Pioglitazone Hcl | Pioglitazone Hcl | 151 | 32 |
| Mupirocin | Mupirocin | 149 | 64 |
| Synjardy | Empagliflozin/Metformin Hcl | 149 | 23 |
| Halobetasol Propionate | Halobetasol Propionate | 147 | 30 |
| Vemlidy | Tenofovir Alafenamide | 147 | 16 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 142 | 26 |
| Sertraline Hcl | Sertraline Hcl | 141 | 20 |
| Donepezil Hcl | Donepezil Hcl | 131 | 18 |
| Meloxicam | Meloxicam | 124 | 33 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 118 | 17 |
| Metformin Hcl Er | Metformin Hcl | 117 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 115 | 28 |
| Fluocinonide | Fluocinonide | 114 | 35 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 114 | 34 |
| Nifedipine Er | Nifedipine | 113 | 19 |
| Xarelto | Rivaroxaban | 110 | 15 |
| Hydrochlorothiazide | Hydrochlorothiazide | 106 | 23 |
| Labetalol Hcl | Labetalol Hcl | 100 | 18 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 98 | 80 |
| Nebivolol Hcl | Nebivolol Hcl | 91 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 90 | 17 |
| Memantine Hcl | Memantine Hcl | 90 | 12 |
| Restasis | Cyclosporine | 89 | 12 |
| Mirtazapine | Mirtazapine | 88 | 19 |
| Ezetimibe | Ezetimibe | 87 | 16 |
| Dexlansoprazole Dr | Dexlansoprazole | 86 | 18 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 81 | 24 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 81 | 18 |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 80 | 12 |
| Ciclopirox | Ciclopirox Olamine | 78 | 16 |
| Procto-Med Hc | Hydrocortisone | 78 | 26 |
| Atenolol | Atenolol | 77 | 18 |
| Rybelsus | Semaglutide | 76 | 15 |
| Hydrocortisone | Hydrocortisone | 75 | 24 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 73 | 12 |
| Repaglinide | Repaglinide | 72 | 12 |
| Creon | Lipase/Protease/Amylase | 71 | 15 |
| Methimazole | Methimazole | 71 | 13 |
| Metoprolol Tartrate | Metoprolol Tartrate | 71 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 67 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 67 | 15 |
| Amoxicillin | Amoxicillin | 66 | 55 |
| Olanzapine | Olanzapine | 66 | 20 |
| Alendronate Sodium | Alendronate Sodium | 64 | 14 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 64 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 63 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 63 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 62 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 61 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 61 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 59 | 21 |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 59 | 11 |
| Nystatin | Nystatin | 56 | 12 |
| Lidocaine | Lidocaine | 54 | 16 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 54 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 54 | 29 |
| Loperamide | Loperamide Hcl | 52 | 39 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 50 | 42 |
| Prednisone | Prednisone | 49 | 27 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 48 | suppressed |
| Torsemide | Torsemide | 46 | suppressed |
| Folic Acid | Folic Acid | 45 | 12 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 42 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 42 | suppressed |
| Ketoconazole | Ketoconazole | 42 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 42 | 25 |
| Levofloxacin | Levofloxacin | 41 | 36 |
| Prolia | Denosumab | 41 | 26 |
| Acarbose | Acarbose | 40 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 40 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 39 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 38 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 38 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 37 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 37 | suppressed |
| Mupirocin | Mupirocin Calcium | 37 | 16 |
| Entecavir | Entecavir | 35 | suppressed |
| Telmisartan | Telmisartan | 35 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 34 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 34 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 34 | suppressed |
| Spironolactone | Spironolactone | 34 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 32 | suppressed |
| Myrbetriq | Mirabegron | 32 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 31 | 21 |
| Edarbi | Azilsartan Medoxomil | 31 | suppressed |
| Gemfibrozil | Gemfibrozil | 31 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 31 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 30 | suppressed |
| Cilostazol | Cilostazol | 30 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 30 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 29 | suppressed |
| Lansoprazole | Lansoprazole | 29 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 27 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 27 | suppressed |
| Acyclovir | Acyclovir | 26 | 18 |
| Febuxostat | Febuxostat | 26 | suppressed |
| Naproxen | Naproxen | 26 | 15 |
| Fluocinolone Acetonide | Fluocinolone Acetonide | 25 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 23 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 23 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 22 | 17 |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Synthroid | Levothyroxine Sodium | 22 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Clobetasol Emollient | Clobetasol Propionate/Emoll | 21 | suppressed |
| Proctozone-Hc | Hydrocortisone | 21 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 20 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 20 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 20 | 11 |
| Unifine Pentips | Pen Needle, Diabetic | 20 | suppressed |
| Clotrimazole | Clotrimazole | 19 | suppressed |
| Ibuprofen | Ibuprofen | 19 | 16 |
| Incruse Ellipta | Umeclidinium Bromide | 19 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 18 | 14 |
| Silodosin | Silodosin | 18 | suppressed |
| Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate | 18 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 18 | suppressed |
| Trulicity | Dulaglutide | 18 | suppressed |
| Dutasteride | Dutasteride | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 17 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 15 | suppressed |
| Irbesartan | Irbesartan | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Atacand | Candesartan Cilexetil | 14 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 14 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 14 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 14 | suppressed |
| Econazole Nitrate | Econazole Nitrate | 13 | suppressed |
| Lubiprostone | Lubiprostone | 13 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Pentoxifylline | Pentoxifylline | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 11 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Clarithromycin | Clarithromycin | 11 | 11 |
| Estradiol | Estradiol | 11 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 11 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $104.94 · 6 records | GlaxoSmithKline, LLC. | Fluad, Flucelvax, TRELEGY ELLIPTA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error